Immunotherapeutics

Rossen Donev (Head of Research, MicroPharm Limited, UK)

$314.95

Hardback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Academic Press Inc
11 March 2022

DNA & Genome; Biochemistry; Molecular biology; Cellular biology (cytology)

Series: Advances in Protein Chemistry and Structural Biology

Immunotherapeutics, Volume 129 in the Advances in Protein Chemistry and Structural Biology series highlights new advances in the field, with this new volume presenting interesting chapters on a variety of topics, including Vaccines for the prophylaxis and treatment of HPV, Lung-targeted RNA-based therapeutics, Clostridium difficile: Current overview and future perspectives, Antivenoms for treatment of snake bites, Natural killer cell-based strategies for immunotherapy of cancer, Immunological insights of selectins in human disease mechanism, Current update, challenges, and future aspects of immunotherapeutics in non-small cell lung cancer, In silico interaction analysis of NEMO binding domain peptide on the NFkB protein, and much more.

Edited by: Rossen Donev (Head of Research MicroPharm Limited UK)
Imprint: Academic Press Inc
Country of Publication: United Kingdom
Dimensions: Height: 229mm, Width: 152mm,
Weight: 880g
ISBN: 9780323992275
ISBN 10: 0323992277
Series: Advances in Protein Chemistry and Structural Biology
Pages: 492
Publication Date: 11 March 2022
Audience: Professional and scholarly , Undergraduate
Format: Hardback
Publisher's Status: Active

1. In silico tools and databases for designing cancer immunotherapy Anjali Dhall, Shipra Jain, Neelam Sharma, Leimarembi Devi Naorem, Dilraj Kaur, Sumeet Patiyal, and Gajendra P.S. Raghava2. Immunotherapeutic approaches for HPV-caused cervical cancerSeyed Amirreza Fatemi, Nadia Seifi, Shiva Rasekh, Sogand Amiri, Seyed Mohammad Iman Moezzi, Ashkan Bagheri, Shirin Fathi, and Manica Negahdaripour3. Natural killer cell-based strategies for immunotherapy of cancerOndrej Vanek, Barbora Kalousková, Celeste Abreu, Shiva Nejadebrahim and Ondrej Skorepa4. Noncoding RNAs as novel immunotherapeutic tools against cancer Maninder Kaur, Bhavneet Kaur, Monidipa Konar, and Sadhna Sharma5. Immunological insights of selectins in human disease mechanism Chandrabose Selvaraj, Rajaram Abhirami, Rajendran Vijayakumar, Faiz Abdulaziz Alfaiz, and Sanjeev Kumar Singh6. CoVaccine HT™ adjuvant is superior to Freund's in eliciting ovine polyclonal antibodies against human tumor necrosis factor-alphaOwen R. Griffiths, John Landon, R. Keith Morris, Philip E. James, and Rachel A. Adams7. Clostridioides difficile: Current overview and future perspectives Joanna Giles and April Roberts8. A computational model revealing the immune-related hub genes and key pathways involved in rheumatoid arthritis (RA) Ambritha Balasundaram, S. Udhaya Kumar, and C. George Priya Doss9. Understanding the activating mechanism of the immune system against COVID-19 by Traditional Indian Medicine: Network pharmacology approach D. Thirumal Kumar, M.S. Shree Devi, S. Udhaya Kumar, Annie Sherlin, Aishwarya Mathew, M. Lakshmipriya, P. Sathiyarajeswaran, R. Gnanasambandan, R. Siva, R. Magesh, and C. George Priya Doss10. Immunotherapeutic interventions in Parkinson's disease: Focus on a-Synuclein Upasana Ganguly, Sukhpal Singh, Sasanka Chakrabarti, Adesh K. Saini, and Reena V. Saini11. Antivenom: An immunotherapy for the treatment of snakebite envenoming in sub-Saharan AfricaMender M. Mender, Fiona Bolton, Colin Berry, and Mark Young

Rossen Donev received his PhD degree in 1999 from the Institute of Molecular Biology, Bulgarian Academy of Sciences. He did postdoctoral training at Imperial Cancer Research Fund, UK (renamed after the merger with Cancer Research Campaign to Cancer Research UK, London Research Institute) and Cardiff University. In 2007 he was awarded a New Investigator Grant Award from the Medical Research Council (UK) to establish himself as an independent Principle Investigator. In 2010 Dr. Donev was appointed Senior Lecturer at Swansea University. In 2016 Dr. Donev joined MicroPharm Ltd (UK) where currently he is Head of Research. He has published more than 60 research papers, chaired scientific meetings and given invited plenary talks. Rossen Donev has consulted on projects related to development of treatments for neurodevelopmental disorders and cancer therapies. He serves as Editor-in-Chief of the Advances in Protein Chemistry and Structural Biology and on editorial board of several other journals. His research interests include signaling pathways involved in neuropsychiatric disorders and tumor escape from the immune system, and development of therapeutic strategies for their treatment. More recently he has focused on development of immunotherapeutics for non-systemic applications.